XML 140 R94.htm IDEA: XBRL DOCUMENT v3.25.4
Fair value measurements - Narrative (Details)
12 Months Ended
Aug. 30, 2021
₪ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Aug. 15, 2024
shares
Aug. 30, 2021
$ / shares
shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of securities issued per warrant exercised (in shares) 1       1
Exercise price (USD per share) | (per share) ₪ 11.50       $ 0.1
Days after completion of transaction in which award is exercisable 30 days        
Expiration period 5 years        
Price per share, company redemption option (USD per share) | ₪ / shares ₪ 0.01        
Minimum share price of company stock, in which company can redeem warrants (USD per share) | ₪ / shares ₪ 18        
Trading days within a 30-trading day period 20 days        
Trading day period 30 days        
Warrants and Rights Outstanding | $   $ 11      
Stockholders receive contingent consideration | $   30,000,000      
AssetAcquisitionPriceOfAcquisition | $   15,000,000      
Contingent earn-out consideration | $   $ 1,401,000      
Restricted stock          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)   7,500,000      
Ordinary shares and vested restricted stock units          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)   15,000,000      
The Sponsor | TWC Tech Holdings II Corp. (“TWC")          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     13,500,000    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC")          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     7,500,000    
Contingent consideration threshold trading days     20 days    
Contingent consideration threshold consecutive trading days     30 days    
Contingent consideration price adjustment expiration period     7 years    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche one          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     3,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares     $ 12.50    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche two          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     3,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares     $ 15.00    
The Sponsor | Restricted stock | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche three          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     1,500,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares     $ 30.00    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC")          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     15,000,000    
Contingent consideration threshold trading days     20 days    
Contingent consideration threshold consecutive trading days     30 days    
Contingent consideration terms, performance period     5 years    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche one          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     5,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 12.5 $ 12.50    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche two          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     5,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   15 $ 15.00    
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | Ordinary shares and vested restricted stock units | TWC Tech Holdings II Corp. (“TWC") | Reverse recapitalization agreement, tranche three          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Number of shares (in shares)     5,000,000    
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares   $ 17.5 $ 17.5    
Level 3          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Contingent earn-out consideration | $   $ 1,401,000      
Public Warrant Liability          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Class of warrant or right, outstanding (in shares) 20,000,000   19,878,580 19,999,449 20,000,000
Exercise price (USD per share) | $ / shares   $ 11.5      
Exercise of public warrants (in shares)     6,803,085    
Private Placement Warrants          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Class of warrant or right, outstanding (in shares) 9,666,667       9,666,667
Exercise of public warrants (in shares)   3,306,000      
Private Placement Warrants | Level 3          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Derivative liability, measurement input   0      
Net Share Settlement          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Exercise of public warrants (in shares)   6,798,440      
cash exercise [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Class of warrant or right, outstanding (in shares)   4,645      
Exercise of public warrants (in shares)   4,645      
Warrant Redemption          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Class of warrant or right, outstanding (in shares)   116,224